基因技術 GENE 深 滬
已收盤 12-16 16:00:00 美东时间
0.765
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.765
- 總市值 370.81万
- 52周最高 3.5624
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.6666
- 委 比 0.00%
- 總股本 484.72万
- 歷史最高 803.7687
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.6666
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Collaborates With GENEWIZ To Advance Genomics-Driven, Precision Kidney Disease Care
Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life SciencesProvides vital insights through sophisticated genomic sequencing and
07-31 20:40
POLARIS INTRODUCES THE ALL-NEW RANGER 500, STARTING AT UNDER $10,000
Built to deliver value and versatility to help make outdoor chores easier MINNEAPOLIS, July 29, 2025 /PRNewswire/ -- Polaris Off Road, the world leader in powersports and off-road innovation...
07-30 03:31
Genie Energy to Report Second Quarter 2025 Results
Genie Energy Ltd. will announce its Q2 2025 financial and operational results on August 7, 2025, via a press release and its website, followed by an SEC filing. A conference call at 8:30 AM EST will discuss results, business outlook, and strategy. Investors can dial in using the provided numbers and access code. A replay will be available post-call, and the release contains forward-looking statements subject to risks.
07-29 21:00
尧景基因心衰治疗小核酸药物获专利授权
近日，热景生物旗下北京尧景基因技术有限公司一项针对心力衰竭的小核酸药物专利正式获得授权。值得关注的是，目前全球范围内尚未有同类疗法进入临床试验阶段。此次成果的突...
07-28 16:39
ROBERT HALF REPORTS SECOND-QUARTER FINANCIAL RESULTS
MENLO PARK, Calif., July 23, 2025 /PRNewswire/ -- Robert Half Inc. (NYSE: RHI) today reported revenues and earnings for the second quarter ended June 30, 2025. For the three months ended Jun...
07-24 04:05
Precision BioSciences shares are trading higher after the company was granted FDA orphan drug designation for PBGENE-DMD in Duchenne muscular dystrophy.
Precision BioSciences shares are trading higher after the company was granted F...
07-23 19:05
媒体视点 | 跑出创新“加速度”——从科创板六年看资本市场助力“硬科技”进阶
登录新浪财经APP 搜索【信披】查看更多考评等级 （来源：安徽上市公司协会） 7月22日，科创板将迎来六岁生日。六年来，这个资本市场改革的“试...
07-23 16:59
云顶新耀自研AI+mRNA技术平台，核心产品已进入临床阶段｜最前线
2025年来，mRNA领域颇有“复苏”的迹象。6月底，艾伯维宣布斥资21亿美元收购体内CAR-T疗法公司Capstan Therapeutics；而BioNT...
07-18 16:29
Precision Biosciences Announced dditional Preclinical Data For PBGENE-DMD, In Vivo Gene Editing Approach For Duchenne Muscular Dystrophy (DMD), Clinical Trial Application Submission Expected In 2025 With Clinical Data Expected In 2026
New preclinical data for the PBGENE-DMD final clinical candidate demonstrates an increase in dystrophin positive muscle cells across key muscle types, potentially driven by editing of muscle satellite cells.PBGENE-DMD is
07-16 19:05
